Drug Type Small molecule drug |
Synonyms NMPD 06, NMPD06 |
Target |
Mechanism CLCN1 inhibitors(chloride voltage-gated channel 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization NMD Pharma A/SStartup |
Active Organization- |
Inactive Organization NMD Pharma A/SStartup |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuromuscular Diseases | Preclinical | DK | NMD Pharma A/SStartup | 07 Jul 2023 |